Tarsus Pharmaceuticals, Inc. (TARS) › Shareholders' EquityTarsus Pharmaceuticals, Inc. (TARS) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: -$44.0K2018: -$1.35M2019: -$6.00M2020: $165.98M2021: $166.73M2022: $192.90M2023: $196.99M2024: $224.53M2025: $343.43M$343.43M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$343.43M+53.0%2024$224.53M+14.0%2023$196.99M+2.1%2022$192.90M+15.7%2021$166.73M+0.5%2020$165.98M+2864.0%2019-$6.00M-343.5%2018-$1.35M-2977.3%2017-$44.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share